Cargando…
Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway
CONTEXT: Shenmai Injection (SMI) is usually used to treat atherosclerotic coronary heart disease and viral myocarditis in China. However, the effect of SMI on multidrug resistance has not been reported. OBJECTIVE: To investigate the reversal effect of SMI in adriamycin (ADR) resistant breast cancer...
Autores principales: | Yang, Lin, Zhang, Chengda, Chen, Jiaoting, Zhang, Sheng, Pan, Guixuan, Xin, Yanfei, Lin, Lin, You, Zhenqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170370/ https://www.ncbi.nlm.nih.gov/pubmed/32251615 http://dx.doi.org/10.1080/13880209.2020.1742167 |
Ejemplares similares
-
Quzhou Fructus Aurantii Extract suppresses inflammation via regulation of MAPK, NF-κB, and AMPK signaling pathway
por: Li, Lili, et al.
Publicado: (2020) -
Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators
por: Zhang, Sheng, et al.
Publicado: (2019) -
An Overview of Systematic Reviews of Shenmai Injection for Healthcare
por: Lu, Ling-yan, et al.
Publicado: (2014) -
Anaphylactoid reactions induced by Shuanghuanglian injection and Shenmai injection and metabolomics analysis
por: Zhang, Chi, et al.
Publicado: (2023) -
Preparation of psoralen polymer–lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells
por: Huang, Qingqing, et al.
Publicado: (2018)